Clinical trials

  • GA68-ONCOFAP for Colorectal cancer | Gastric cancer | Pancreatic ductal adenocarcinoma | Invasive lobular breast cancer | Epithelial ovarian cancer
  • DOSTARLIMAB for Colon adenocarcinoma|T4N0 colon cancer|Stage III colon cancer|MMRp/MSS colon cancer
  • ROCATINLIMAB for Asthma
  • AZACITIDINE for VEXAS syndrome
  • NIRSEVIMAB for Respiratory syncytial virus (RSV) infection
  • pembrolizumab for Advanced solid tumors
  • RNMB1, RNMB2, NMBPBAS1, RNMB3, NEISSERIA MENINGITIDIS, SEROGROUP C, POLYSACCHARIDE, CONJUGATED TO TETANUS TOXOID, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP Y POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN for Meningococcal disease
  • FINERENONE for Chronic kidney disease
  • AZENOSERTIB for High-grade serous ovarian cancer | Fallopian tube cancer | Primary peritoneal carcinoma
  • APIXABAN for Atrial fibrillation
  • Baricitinib for HIV-1 infection
  • Eptinezumab for Migraine | Chronic migraine | Episodic migraine